Search

everythinglearnresearchcommunity

for

Search:↓

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Most children with MIS-C showed significant improvement by 6 months.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Pharmacist-led care significantly improved post-COVID symptoms.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

Post-COVID-19 patients are at risk for hair loss.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

COVID-19 affects multiple body systems, not just the lungs.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

COVID-19 can cause temporary hair loss.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Age, health conditions, race, and gender affect COVID-19 risk.

Genetic differences affect COVID-19 severity and treatment development.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Cepharanthine shows promise as a COVID-19 treatment.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.